• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺乳头状癌患者全甲状腺切除术后永久性低钙血症风险预测模型的建立与验证

Development and validation of risk prediction models for permanent hypocalcemia after total thyroidectomy in patients with papillary thyroid carcinoma.

作者信息

Cao BoHan, Zhang CanGang, Jiang MingMing, Yang Yi, Liu XiCai

机构信息

Department of General Surgery, Benxi Central Hospital of China Medical University, No. 29 Shengli Street, Mingshan District, Benxi, 117000, Liaoning Province, China.

Department of General Surgery, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, 110004, Liaoning Province, China.

出版信息

Sci Rep. 2025 Mar 18;15(1):9348. doi: 10.1038/s41598-025-93867-9.

DOI:10.1038/s41598-025-93867-9
PMID:40102549
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11920412/
Abstract

Hypocalcemia is a common complication and can be permanent in patients following total thyroidectomy (TT). The aim of this study was to identify factors associated with permanent hypocalcemia and to develop a validated risk prediction model for permanent hypocalcemia to assist surgeons in the appropriate follow-up of high-risk patients regarding supplemental therapy. We included data of 92 patients with papillary thyroid carcinoma (PTC) undergoing TT who were randomly allocated in a 7:3 ratio to a training set (n = 65) and validation set (n = 27). Univariate and multivariate logistic regression analyses revealed significant correlations of permanent hypocalcemia with parathyroid hormone (PTH) at postoperative month 1 (IM PTH), IM calcium (Ca), and IM phosphorus (P). These variables were constructed two models. Model 1 used the three indicators listed above; model 2 also included tumor, node, metastasis staging. The receiver operating characteristic (ROC) curve analysis showed that the areas under the curve (AUC) for models 1 and 2 were high for both the training set (0.905/0.913) and the validation set (0.894/0.800). Calibration curves showed good agreement between the incidence of permanent hypocalcemia estimated using the predictive models and the actual incidence. Model 1 may be more concise and convenient for clinical use.

摘要

低钙血症是全甲状腺切除术后(TT)患者常见的并发症,且可能是永久性的。本研究的目的是确定与永久性低钙血症相关的因素,并开发一个经过验证的永久性低钙血症风险预测模型,以协助外科医生对高危患者进行适当的补充治疗随访。我们纳入了92例行TT的甲状腺乳头状癌(PTC)患者的数据,这些患者以7:3的比例随机分配到训练集(n = 65)和验证集(n = 27)。单因素和多因素逻辑回归分析显示,永久性低钙血症与术后第1个月的甲状旁腺激素(PTH)、第1个月的血钙(Ca)和第1个月的血磷(P)显著相关。利用这些变量构建了两个模型。模型1使用上述三个指标;模型2还包括肿瘤(T)、淋巴结(N)、转移(M)分期。受试者工作特征(ROC)曲线分析表明,模型1和模型2在训练集(0.905/0.913)和验证集(0.894/0.800)中的曲线下面积(AUC)都很高。校准曲线显示,使用预测模型估计的永久性低钙血症发生率与实际发生率之间具有良好的一致性。模型1在临床应用中可能更简洁方便。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4707/11920412/4b035753c4a3/41598_2025_93867_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4707/11920412/4c99b07b5664/41598_2025_93867_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4707/11920412/312d99c0b513/41598_2025_93867_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4707/11920412/315c2fd0700a/41598_2025_93867_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4707/11920412/04f626bb64b2/41598_2025_93867_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4707/11920412/3dc97fa8452c/41598_2025_93867_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4707/11920412/ea7ba0a71f8d/41598_2025_93867_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4707/11920412/d8fbc17859e3/41598_2025_93867_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4707/11920412/4b035753c4a3/41598_2025_93867_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4707/11920412/4c99b07b5664/41598_2025_93867_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4707/11920412/312d99c0b513/41598_2025_93867_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4707/11920412/315c2fd0700a/41598_2025_93867_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4707/11920412/04f626bb64b2/41598_2025_93867_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4707/11920412/3dc97fa8452c/41598_2025_93867_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4707/11920412/ea7ba0a71f8d/41598_2025_93867_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4707/11920412/d8fbc17859e3/41598_2025_93867_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4707/11920412/4b035753c4a3/41598_2025_93867_Fig8_HTML.jpg

相似文献

1
Development and validation of risk prediction models for permanent hypocalcemia after total thyroidectomy in patients with papillary thyroid carcinoma.甲状腺乳头状癌患者全甲状腺切除术后永久性低钙血症风险预测模型的建立与验证
Sci Rep. 2025 Mar 18;15(1):9348. doi: 10.1038/s41598-025-93867-9.
2
The most reliable time point for intact parathyroid hormone measurement to predict hypoparathyroidism after total thyroidectomy with central neck dissection to treat papillary thyroid carcinoma: a prospective cohort study.在治疗甲状腺乳头状癌的甲状腺全切除加中央区颈淋巴结清扫术后,预测甲状旁腺功能低下症的最可靠时间点是完整甲状旁腺激素测量:一项前瞻性队列研究。
Eur Arch Otorhinolaryngol. 2020 Feb;277(2):549-558. doi: 10.1007/s00405-019-05693-1. Epub 2019 Oct 16.
3
Postoperative Hypoparathyroidism After Total Thyroidectomy in Children.儿童全甲状腺切除术后的甲状旁腺功能减退症
J Surg Res. 2020 Aug;252:63-68. doi: 10.1016/j.jss.2020.02.018. Epub 2020 Mar 29.
4
Prediction Model of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma.甲状腺乳头状癌颈淋巴结转移预测模型。
Cancer Control. 2024 Jan-Dec;31:10732748241295347. doi: 10.1177/10732748241295347.
5
Parathyroid hormone-based algorithm reduces complications after total thyroidectomy.基于甲状旁腺激素的算法可降低全甲状腺切除术后的并发症。
Surgery. 2025 Feb;178:108933. doi: 10.1016/j.surg.2024.10.024. Epub 2024 Nov 29.
6
Parathyroid hormone measurement in prediction of hypocalcaemia following thyroidectomy.甲状旁腺激素测定在预测甲状腺切除术后低钙血症中的应用
J Coll Physicians Surg Pak. 2014 Feb;24(2):82-7.
7
Inadvertent parathyroidectomy during total thyroidectomy and central neck dissection for papillary thyroid carcinoma.在甲状腺乳头状癌全甲状腺切除术及中央区颈清扫术中意外甲状旁腺切除。
Surgery. 2017 Mar;161(3):712-719. doi: 10.1016/j.surg.2016.08.021. Epub 2016 Oct 13.
8
In Situ Preservation of Parathyroid Gland With Vasculature for Papillary Thyroid Carcinoma Is Associated With Higher PTH Levels After Total Thyroidectomy.原位保留带血管甲状旁腺组织对甲状腺癌全甲状腺切除术后甲状旁腺激素水平的影响
Ear Nose Throat J. 2022 Feb;101(2):95-104. doi: 10.1177/01455613211039807. Epub 2021 Sep 2.
9
Role of postoperative intact serum PTH as an early predictor of severe post-thyroidectomy hypocalcemia: a prospective study.术后完整血清甲状旁腺素水平作为甲状腺切除术后严重低钙血症早期预测指标的作用:一项前瞻性研究。
J Endocrinol Invest. 2021 Sep;44(9):1961-1970. doi: 10.1007/s40618-021-01511-w. Epub 2021 Jan 27.
10
A prospective evaluation of quick intraoperative parathyroid hormone assay at the time of skin closure in predicting clinically relevant hypocalcemia after thyroidectomy.在甲状腺切除术后,于皮肤缝合时进行快速术中甲状旁腺激素检测,以预测临床相关低钙血症的前瞻性评估。
World J Surg. 2012 Jun;36(6):1300-6. doi: 10.1007/s00268-012-1561-9.

本文引用的文献

1
A nomogram prediction model for hungry bone syndrome in dialysis patients with secondary hyperparathyroidism after total parathyroidectomy.全甲状腺切除术后甲状旁腺功能亢进透析患者饥饿骨综合征的列线图预测模型。
Eur J Med Res. 2024 Mar 28;29(1):208. doi: 10.1186/s40001-024-01801-y.
2
Development of a tool to calculate the probability of hypocalcemia after total thyroidectomy: a prospective study.一种计算甲状腺全切除术后低钙血症发生概率工具的开发:一项前瞻性研究。
Langenbecks Arch Surg. 2024 Jan 9;409(1):33. doi: 10.1007/s00423-024-03229-8.
3
The application of subcapsular saline injection to preserve the parathyroid gland during thyroidectomy.
甲状腺切除术中应用包膜下注射生理盐水以保护甲状旁腺。
Heliyon. 2023 Nov 2;9(11):e21543. doi: 10.1016/j.heliyon.2023.e21543. eCollection 2023 Nov.
4
Validating the risk of hypoparathyroidism after total thyroidectomy in a population-based cohort: plea for improved follow-up.验证基于人群的全甲状腺切除术后甲状旁腺功能减退风险:呼吁改善随访。
Br J Surg. 2024 Jan 3;111(1). doi: 10.1093/bjs/znad366.
5
Postoperative hypoparathyroidism after thyroid operation and exploration of permanent hypoparathyroidism evaluation.甲状腺手术后甲状旁腺功能减退症及永久性甲状旁腺功能减退症评估的探讨。
Front Endocrinol (Lausanne). 2023 May 31;14:1182062. doi: 10.3389/fendo.2023.1182062. eCollection 2023.
6
Medullary Thyroid Cancer: Updates and Challenges.甲状腺髓样癌:更新与挑战。
Endocr Rev. 2023 Sep 15;44(5):934-946. doi: 10.1210/endrev/bnad013.
7
Thyroid cancer.甲状腺癌。
Lancet. 2023 May 6;401(10387):1531-1544. doi: 10.1016/S0140-6736(23)00020-X. Epub 2023 Apr 3.
8
Construction and validation of a predictive model for hypocalcemia after parathyroidectomy in patients with secondary hyperparathyroidism.构建并验证继发性甲状旁腺功能亢进患者甲状旁腺切除术后低钙血症的预测模型。
Front Endocrinol (Lausanne). 2022 Nov 30;13:1040264. doi: 10.3389/fendo.2022.1040264. eCollection 2022.
9
Definition and diagnosis of postsurgical hypoparathyroidism after thyroid surgery: meta-analysis.甲状腺手术后甲状旁腺功能减退症的定义和诊断:荟萃分析。
BJS Open. 2022 Sep 2;6(5). doi: 10.1093/bjsopen/zrac102.
10
Predictive value of postoperative day 1 parathyroid hormone levels for early and late hypocalcaemia after thyroidectomy.术后第 1 天甲状旁腺激素水平对甲状腺切除术后早期和晚期低钙血症的预测价值。
Langenbecks Arch Surg. 2022 Jun;407(4):1653-1658. doi: 10.1007/s00423-022-02480-1. Epub 2022 Mar 5.